(Q52648220)

5 May 2018

title

Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. (English)

1 reference

5 May 2018

1 reference

Ruëff F

1

1 reference

5 May 2018

Wolf H

2

1 reference

5 May 2018

Schnitker J

3

1 reference

5 May 2018

Ring J

4

1 reference

5 May 2018

Przybilla B

5

1 reference

5 May 2018

publication date

1 June 2004

1 reference

5 May 2018

published in

Allergy

1 reference

5 May 2018

volume

59

1 reference

5 May 2018

issue

6

1 reference

5 May 2018

page(s)

589-595

1 reference

5 May 2018

Incidence and severity of anaphylactoid reactions to colloid volume substitutes

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00505.X

Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00505.X

Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00505.X

Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00505.X

Development of sensitisation or tolerance following repeated OVA inhalation in BALB/cJ mice. Dose-dependency and modulation by the Al(OH)3 adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00505.X

Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2004.00505.X

10.1111/J.1398-9995.2004.00505.X

21 January 2018

Identifiers

DOI

1 reference

5 May 2018

1 reference

5 May 2018